Abvc Biopharma Stock Forecast

Buy or Hold candidate since Nov 14, 2025 Loss -0.68%

The ABVC BioPharma, Inc. stock price fell by -0.685% on the last day (Monday, 17th Nov 2025) from $2.92 to $2.90. During the last trading day the stock fluctuated 2.07% from a day low at $2.90 to a day high of $2.96. The price has been going up and down for this period, and there has been a -2.03% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -18 thousand shares and in total, 49 thousand shares were bought and sold for approximately $141.37 thousand.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect ABVC BioPharma, Inc. stock with a 90% probability to be traded between $2.63 and $3.27 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stock seldom manage to go directly from the bottom of a trend up to the top. Stock turning up in the middle of a horizontal trend are therefore considered to be potential runners.

ABVC Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, October 29, 2025, and so far it has risen 4.69%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ABVC BioPharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.95. On a fall, the stock will find some support from the short-term average at $2.89. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for ABVC BioPharma, Inc. stock

ABVC BioPharma, Inc. finds support from accumulated volume at $2.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0600 between high and low, or 2.07%. For the last week the stock has had daily average volatility of 4.20%.

Our recommended stop-loss: $2.75 (-5.34%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (ABVC) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect ABVC BioPharma, Inc. to open at $2.92, and during the day (based on 14 day Average True Range), to move between $2.82 and $2.98, which gives a possible trading interval of +/-$0.151 (+/-5.36%) up or down from last closing price. If ABVC BioPharma, Inc. takes out the full calculated possible swing range there will be an estimated 5.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.85 (1.72%) than the resistance at $2.98 (2.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ABVC BioPharma, Inc. stock A Buy?

ABVC BioPharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.049 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.92 ( 0.690%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk